AssetMark’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding FBRX
AssetMark's FBRX Position: Q3 2026 in Review
AssetMark sold out of Forte Biosciences (FBRX) in Q3 2026, closing a stake of 34 shares — an estimated $723 sold.
AssetMark first reported a position in FBRX in Q3 2025 and held it in 4 quarters. The position peaked at $1.58K in Q4 2025. 2 funds tracked by Wall St. Rank hold FBRX as of Q3 2026.
- AssetMark reported no remaining Forte Biosciences position as of Q3 2026 after selling out during the quarter.
- AssetMark sold 34 Forte Biosciences shares in Q3 2026, an estimated $723.
- AssetMark first reported a position in Forte Biosciences in Q3 2025 and held it in 4 quarters.
- AssetMark's Forte Biosciences position peaked at $1.58K in Q4 2025.
- 2 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.